Hepatitis D screening: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) |
||
| Line 17: | Line 17: | ||
{{For|Recommendations for Persons Who Should Be Tested for HBV Infection|Hepatitis B screening}} | {{For|Recommendations for Persons Who Should Be Tested for HBV Infection|Hepatitis B screening}} | ||
{{For|Recommendations for HCC Screening|Hepatitis B screening}} | |||
==References== | ==References== | ||
Revision as of 04:42, 6 August 2014
|
Hepatitis D |
|
Diagnosis |
|
Treatment |
|
Hepatitis D screening On the Web |
|
American Roentgen Ray Society Images of Hepatitis D screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jolanta Marszalek, M.D. [2] João André Alves Silva, M.D. [3]
Overview
Screening
All patients with current or previous IV drug use history should be evaluated for hepatitis B. However, screening is not recommended in asymptomatic HBsAg positive patients. Preventive measures and screening may be applied in:
- HBsAg positive patients, who have acute or chronic hepatitis D. The follow-up procedures should be equal, regardless of co-infection status with hepatitis D
- Patients who: have acute hepatitis B, are not HBsAg positive and who are IgM anti-HBc positive may be tested for HDV.
- Patients with positive HBsAg and/or HDV antibody should be alerted not to share items such as razors, eating or drinking utensils.
- Patients without immunity to the virus should be vaccinated
The general population, without risk for HBV and /or HDV, does not need screening.